TANG PRIZE/Drug developed by Tang Prize laureate plays role in COVID-19 treatment
11/25/2021 04:45 PM
Japanese immunologist Tadamitsu Kishimoto never expected that a drug he and his research team at Osaka University developed to treat rheumatoid arthritis (RA) would one day play a role in the fight against a global pandemic.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
U.S. research funding cuts hurt scientific progress: Tang Prize laureatesThe 2026 Tang Prize laureates in Biopharmaceutical Science warned Saturday that cuts to U.S. government research funding could slow scientific progress and reduce opportunities for young researchers, with potentially long-term consequences for the scientific workforce.09/19/2026 07:39 PM
Find pivotal moments that shape history: Tang Prize Sinology laureateGe Zhaoguang (葛兆光) used his platform as the 2026 Tang Prize laureate in Sinology on Saturday to encourage historians to broaden their perspective and focus on identifying pivotal moments that shape history's course.09/19/2026 07:02 PM
Ozone recovery a rare success story: Tang Prize laureate Susan SolomonThe recovery of the Antarctic ozone layer represents a rare example of science and international policy successfully addressing a global environmental threat, said Susan Solomon, whose research on chlorofluorocarbons (CFCs) earned her the 2026 Tang Prize in Sustainable Development.09/19/2026 05:25 PM
Latest
- Sports
Taiwan boosts medal haul in multiple events at Asian Games on Friday
10/02/2026 08:55 PM - Society
Workers at Taiwan snack maker Kuai Kuai extend strike over relocation
10/02/2026 08:45 PM - Business
Chain businesses association seeks more foreign workers
10/02/2026 08:04 PM - Politics
Shen unveils Taipei education platform, Chiang defends free lunches
10/02/2026 06:45 PM - Politics
Taiwan receives first 2 F-16V Block 70s (update)
10/02/2026 06:39 PM


